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Abstract
Purpose: Choosing an appropriate parameter on the computerized treatmentplanning systems (TPSs) influences on the accuracy of dose calculation. Severaldosimetric parameters have been studied to achieve a more accurate dose andqualitative plan. The purpose of this study was to determine the impact ofmaximum control point on the dose calculation on Eclipse TPSs for lungStereotactic Body Radiation Therapy (SBRT) considering the plan quality, thecomputation time and the treatment file size. Methods: Dose distributions for the 8lung SBRT plans with varying maximum control point of 64, 166, and 320 werecalculated by Eclipse TPSs with flattening filter free (FFF) beam. The treatmentdose was prescribed at 85% isodose level of 54 Gy to the planning target volume(PTV). The dosimetric impact can be evaluated from target coverage, conformityindex (CI), homogeneity index (HI), and organ at risk (OAR) doses, while thecomputation time and the file storage space were compared with therecommended number of control point. Results: The use of 64 control points persubfields tended to increase the dose at PTV and OARs comparing with the 166 and320 control point plans, while the HI and CI values were similar. The averageincreases of OARs doses including the spinal cord, heart, esophagus and total lungdepended on the photon beam energy. The higher average control point (AVG)number leaded to increase the computation time and the file size for both 6X-FFFand 10X-FFF photon beams. The correlations between AVG and plan storage spacewere observed in the same ratio as the computation time. Conclusion: Using theminimal number of control point, the quantitative analysis in the PTV and OARsshowed no clinically significant variation in dose, therefore choosing an optimalnumber of fixed control points leaded to balance the plan quality, the computationtime and the file size.
Keywords: Control point, Stereotactic body radiation therapy, Dynamic multileafcollimator, Intensity modulated radiation therapy.
1. IntroductionStereotactic body radiation therapy (SBRT) is analternative treatment option for patients with localizednon-small cell lung cancer. Use of intensity-modulatedradiation therapy (IMRT) technique to treat lung SBRThas been shown to increase the local tumor controlcompared to the standard fractionation treatments.1 TheIMRT can provide the conformal dose distributionaround the target volume by using the dynamic multileafcollimator (DMLC). Several doismetric planning
parameters for the dose calculation in DMLC-IMRTtechnique have been studied to achieve a more accuratedose and qualitative plan. Huang et al2 has reported thedose differences between the Anisotropic AnalyticalAlgorithm (AAA) and ACUROS XB (AXB) in lung SBRTtreatment with flattening filter free (FFF) beams. Park et
al3 determined the optimal grid size and angularincrement for the dose calculation in lung SBRT usingdynamic conformal arc therapy (DCAT). Chung et al4
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found a 2 mm grid size produced a dose difference of2.3% of prescribed dose as compared to 1.5 mm gridsize in an IMRT plan.The control point is one of the dosimetric parametersaffected to the plan quality, the transfer and loadingtimes, and file storage space, as presented in the study ofGoraj et al5. It associates with the specification of apercentage of the set beam monitor units (MU) in aDMLC delivery.6 The DMLC-IMRT treatment planscreated in Eclipse treatment planning system (TPSs) canadjust the number of control point ranging from 64-320control points for each treatment field.7 Theoretically,a higher number of control points results in a highernumber of beam fluence.The purpose of this study was to investigate the effect ofmaximum control point numbers on Eclipse TPSs forlung SBRT plan using DMLC-IMRT technique. Dosevariations in both the planning target volume (PTV) andorgan at risk (OAR), the computation time, and the filestorage space with varying maximum control pointswere analyzed.
2. Methods and MaterialsThe 8 lung SBRT patient data were retrospectivelyselected to estimate the dose variation as a function ofmaximum control point. The computed tomography(CT) images were obtained over the lung region ofpatient through Brilliance Big Bore 16-slice (PhilipsHealthcare, Andover, MA) CT scanner with a slicethickness of 3 mm. A four-dimensional (4D) CT imagesacquired with the real-time position management (RPM)system were used to generate the internal target volume(ITV). Expanding a 0.5 cm margin in the axial plane and1.0 cm margin in the longitudinal plane from the ITVwas defined as the PTV.8 An equivalent diameter of PTVfor all patients was ranging from 3.7 to 6.7 cm. In thisstudy, the OARs included the spinal cord, heart,esophagus and normal lung. The clinical characteristicsof the 8 lung SBRT plans were listed in Table 1.Treating the lung SBRT on True Beam linear accelerator(Varian Medical Systems, Palo Alto, USA) was performedwith a maximum dose rate of 1400 MU / min and 2400MU / min for 6X-FFF and 10X-FFF photon beams,respectively. Dose distributions with varying maximumcontrol point of 64, 166, and 320 were calculated byAcuros XB (AXB) algorithm on Eclipse TPSs version11.0.31 (Varian Medical Systems, Palo Alto, USA) with 2mm grid sizes. The prescription of 85% isodose level of54 Gy to the PTV was specified in this study. The isodosedistributions of the SBRT plans were computed andanalyzed.The quality of each planned dose distribution can beassessed from target coverage, conformity index (CI)and homogeneity index (HI) of the PTVs and the dose
variation of the OARs. Dose homogeneity indexdetermines the uniformity of the dose distributionwithin the target volume. Following the InternationalCommission on Radiation Units and Measurements(ICRU) report number 629-10, the HI is given by
%50
%98%2
D
DDHI  (1)
where D2%, D50% and D98% are the target volume receivingthe 2%, 50% and 98% of prescribed dose, respectively.If the HI equals to zero, the dose distribution of the PTVsis almost homogeneous.The degree of high dose conformity around the PTV canbe evaluated from dose conformity index. Following theRadiation Therapy Oncology Group (RTOG)9-10, the CI isgiven by
TV
VCI RIRTOG  (2)where VRI represents the volume of reference isodoseand TV is the target volume. If the CI equals to 1, thedose distribution is indicated to conform the PTV.According to the King Chulalongkorn Memorial HospitalSBRT protocol, the OARs including the spinal cord, heartand esophagus were evaluated as a maximum dose point,while the total lung was analyzed at the dose to 1000 ccvolume. All DMLC-IMRT plans were transferred from theEclipse TPSs to ARIA oncology information systemversion 11.0.31 (Varian Medical Systems, Palo Alto, USA)and the delivery unit. Both computation time and filestorage space with varying control point were alsocollected and compared with that for the defaultedmaximum number of control point.
3. ResultsThe differences in the average mean dose, HI and CI ofthe PTV derived from a variable number of control pointfor both 6X-FFF and 10X-FFF photon beams weresummarized in Table 2.The 64 control point per subfields tended to increase allPTV mean doses for both 6X-FFF and 10X-FFF beamswhen compared to the 166 and 320 control point plans.For the 6X-FFF beam, the maximum increases of the PTVmean dose were 0.46% (26.7  1.0 cGy) and 0.50% (29.1
 1.5 cGy) for one of the plans using the control point of166 and 320, respectively. For the 10X-FFF beam, themaximum increases of the PTV mean dose were 0.35%(20.9  3.7 cGy) and 0.37% (22.5  1.9 cGy) for one ofthe plans using the control point of 166 and 320,respectively. Although the dose calculation using theminimal control point number leaded to increase thePTV mean dose, the HI and CI do not differedsignificantly among these plans.
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Table 1: Characteristics of the PTV and planning parameters for the 8 lung SBRT patient dataPatient Equivalent diameter ofPTV (cm) Energy (MV) No of treatmentfields Tumor location1 3.7 6X-FFF 9 Left middle lobe2 4.2 10X-FFF 7 Right middle lobe3 5.1 10X-FFF 9 Left middle lobe4 5.1 10X-FFF 7 Right upper lobe5 5.4 6X-FFF 7 Right middle lobe6 6.1 10X-FFF 9 Left lower lobe7 6.4 10X-FFF 9 Right upper lobe8 6.7 6X-FFF 9 Right middle lobe
Table 2: Comparison of average mean dose, HI and CI of the PTV calculated with the 64, 166, and 320 control points for both6X-FFF and 10X-FFF photon beamsItem Max controlpoint number Average value6X-FFF 10X-FFFPTV mean dose 64 5903.9  353.7 cGy 6062.8  356.7 cGy166 5887.8  351.6 cGy 6046.1  354.7 cGy320 5887.1  351.5 cGy 6045.5  354.8 cGyHI 64 0.243 (0.20 - 0.28) 0.238 (0.17 - 0.30)166 0.243 (0.20 - 0.28) 0.238 (0.17 - 0.30)320 0.243 (0.20 - 0.28) 0.238 (0.17 - 0.30)CI 64 0.983 (0.93 - 1.09) 0.998 (0.92-1.06)166 0.977 (0.92 - 1.09) 0.992 (0.91-1.06)320 0.977 (0.92 - 1.09) 0.990 (0.91-1.06)
Table 3 presented the dose differences of the OARsderived from the maximum control point number of 64,166 and 320 for both 6X-FFF and 10X-FFF photonbeams. We found an effect of variable control pointnumber on the maximum dose of heart, esophagus andspinal cord, and the dose to 1000 cc volume of total lung.The maximum dose of the OARs was mostly shown toincrease overall when calculated with the 64 controlpoint for both 6X-FFF and 10X-FFF beams. Themaximum increases of the dose were 0.395% for thespinal cord, and 0.568% for the heart and total lung inthe 6X-FFF beam. For the 10X-FFF beam, the maximumincreasing doses were 0.206% for the total lung, 0.214%for the esophagus, 0.231% for the heart, and 0.505% forthe spinal cord.When the DMLC-IMRT plans were calculated with avariable number of control points, the calculation timeand the file size were differed. Table 4 presented thetime for calculation in the unit of minutes and the size oftreatment plan in the unit of Kilobyte (KB) for both6X-FFF and 10X-FFF photon beams. Comparing with the166 control point plan, the computation time of the 64control point plan was increased by average of 0.12 0.03 and 0.43  0.26 minutes for the 6X-FFF and10X-FFF beams, respectively. Using the lowest control
point number, the storage spaces of treatment plan werereduced by average of 38.50  5.61% and 47.67  5.60%for the 6X-FFF and 10X-FFF beams, respectively, whencompared with the 166 control point plan. Thecomputation time and plan storage space obtained fromthe 166 and 320 control points do not differedsignificantly.
4. DiscussionIn this study, we found that the maximum number ofcontrol point impacts on the plan quality, computationtime and file size. At the lowest number of control point,the dose at the PTV and OARs including the spinal cord,heart, esophagus and total lung tends to increase whencompared with the 166 and 320 control point plans,while the HI is similar. On average, the differences ofPTV mean dose obtained from the 166 and 320 controlpoint plans are within 0.27% and 0.29% of the 64control point plan for both 6X-FFF and 10X-FFF beams,respectively. The average differences of OARs dose whencompared with the 64 control point plan weresummarized in Figure 1. We observed that the dosevariations derived from the 166 and 320 control pointplans do not differ significantly in the dose at the PTVand OARS.
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Table 3: Comparison of the OARs dose derived from the 64, 166, and 320 control point plans for both 6X-FFF and 10X-FFFphoton beamsPatient OARs Location Dose (cGy)64 166 3201 Heart Max 127.2 127.1 127.1Esophagus Max 894.3 891.2 891.2Spinal cord Max 358.3 358.1 358.1Lung V1000cc 119.9 119.7 119.72 Heart Max 96.3 96.2 96.4Esophagus Max - - -Spinal cord Max 85.3 85.2 85.2Lung V1000cc 35.0 35.0 35.03 Heart Max 372.9 372.7 372.5Esophagus Max 1654.1 1651.1 1651.2Spinal cord Max 875.6 872.7 872.7Lung V1000cc 353.4 353.0 352.74 Heart Max 48.8 48.5 48.5Esophagus Max 3638.4 3646.1 3645.4Spinal cord Max 1233.9 1231.3 1231.8Lung V1000cc 17.0 17.7 17.75 Heart Max 1767.6 1757.6 1757.0Esophagus Max 1691.7 1694.8 1694.1Spinal cord Max 941.3 938.1 937.6Lung V1000cc 214.1 212.9 213.16 Heart Max 4396.2 4389.2 4384.5Esophagus Max 1232.7 1231.6 1231.3Spinal cord Max 1507.6 1505.5 1505.5Lung V1000cc 82.2 82.1 82.07 Heart Max 5418.3 5407.2 5405.8Esophagus Max 2051.7 2049.0 2049.1Spinal cord Max 2228.4 2219.0 2217.2Lung V1000cc 73.1 73.1 73.08 Heart Max 4795.3 4791.8 4793.5Esophagus Max 2417.0 2420.1 2420.8Spinal cord Max 4532.3 4539.1 4527.3Lung V1000cc 612.8 612.6 612.1
Table 4: Comparison of the computation time and file size as a function of maximum number of control point for the 8 lungSBRT patient dataPatient Energy (MeV) Computation time (min) Plan storage space (KB)64 166 320 64 166 3201 6X-FFF 4.26 4.39 4.38 362 638 6332 10X-FFF 5.46 5.53 5.54 290 486 4933 10X-FFF 7.50 8.08 8.04 369 667 6574 10X-FFF 6.04 6.27 6.28 289 546 5465 6X-FFF 3.30 3.45 3.48 285 714 8016 10X-FFF 9.54 10.21 10.21 375 780 8117 10X-FFF 12.59 13.19 13.43 374 819 8458 6X-FFF 7.02 7.10 7.18 375 554 558
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Figure1: The average differences of OARs dose comparing with the 64 control point plans for both 6X-FFF and 10X-FFFphoton beams
Table 5: The number of treatment fields and the number of control points per patient per individual treatment field of thelung SBRT patient no 3 and 4Patient No oftreatmentfields Max no ofcontrol points AVG Field no.1 2 3 4 5 6 7 8 93 9 64 64 64 64 64 64 64 64 64 64 64166 118 126 118 117 114 104 119 113 130 122320 118 126 118 117 114 104 119 113 130 1224 7 64 64 64 64 64 64 64 64 64 - -166 124 137 153 117 126 106 109 120 - -320 124 137 153 117 126 106 109 120 - -
The number of control point has a direct effect on thecomputation time and the plan storage space. Ourresults demonstrated the DMLC-IMRT plan with a largernumber of control point require a longer time forcalculation and more space for file storage assummarized in Table 4. Comparing with the 64 controlpoint, the largest increasing of computation time is 0.67and 0.84 minutes using the 166 and 320 control pointsfor the 10X-FFF beam, respectively. It is found to beproportional to the number of control points perindividual treatment field and the number of treatmentfields as presented in Table 5.An equivalent diameter of the PTV for the plan number 3and 4 equals to 5.1 cm, but the number of treatmentfields is different. We found that the higher number oftreatment field, the lower number of average controlpoint (AVG). Moreover we observed that the size of
treatment plan increases in the similar ratio with theincreasing of an AVG. Goraj et al5 reported that thenumber of control points associates with the planstorage space and the file transfer error. Thereforechoosing an optimal number of maximum control pointsfor practical dose calculation is an appropriateparameter for balancing the plan quality, computationtime and file size.
5. ConclusionData analysis of target coverage and OARs showed noclinically significant in dose when varied the maximumcontrol point number. Using the 166 control point canyield a lower dose distribution in PTV and OARs for both6X-FFF and 10X-FFF photon beams, however it requiresa longer computation time and a more space for planstorage.
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